References
- Akolekar R, Beta J, Picciarelli G, Ogilvie C, D’Antonio F. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2015;45:16‐26. doi: 10.1002/uog.14636.
- Anuwutnavin S, Chanprapaph P, Ruangvutilert P, Eammatta M, Tontisirin P. Short-term outcomes after second-trimester genetic amniocentesis in Siriraj Hospital. Int J Gynaecol Obstet. 2014;124:222‐5. doi: 10.1016/j.ijgo.2013.09.019.
- Royal College of Obstetricians and Gynaecologists. Amniocentesis and chorionic villus sampling. Green top guideline no. 8. Accessed March 13th, 2020 at: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_8.pdf
- Tabor A, Philip J, Madsen M, Bang J, Obel EB, Nørgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet. 1986;1:1287‐93. doi: 10.1016/s0140-6736(86)91218-3.
- Bakker M, Birnie E, Robles de Medina P, Sollie KM, Pajkrt E, Bilardo CM. Total pregnancy loss after chorionic villus sampling and amniocentesis: a cohort study. Ultrasound Obstet Gynecol. 2017;49:599‐606. doi: 10.1002/uog.15986.
- Beta J, Lesmes-Heredia C, Bedetti C, Akolekar R. Risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review of the literature. Minerva Ginecol. 2018;70:215‐19. doi: 10.23736/S0026-4784.17.04178-8.
- Prelog PR, Makovec MR, Šimic MV, Sršen TP, Perat M. Individual and contextual factors of nulliparas’ levels of depression, anxiety and fear of childbirth in the last trimester of pregnancy: intimate partner attachment a key factor?. Zdr Varst. 2019;58:112-19. doi: 10.2478/sjph-2019-0015.
- Globevnik Velikonja V, Lozej T, Leban G, Verdenik I, Vrtačnik Bokal E. The quality of life in pregnant women conceiving through in vitro fertilization. Zdr Varst. 2016;55:1-10. doi: 10.1515/sjph-2016-0001.
- Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol. 2019;54:442-51. doi: 10.1002/uog.20353.
- Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368:601-11. doi: 10.1016/S0140-6736(06)69204-0.
- Ogilvie C, Akolekar R. Pregnancy loss following amniocentesis or CVS sampling-time for a reassessment of risk. J Clin Med. 2014;3:741‐46. doi: 10.3390/jcm3030741.
- Alfirevic Z, Navaratnam K, Mujezinovic F. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2017;9:CD003252. doi: 10.1002/14651858.CD003252.pub2.
- Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, et al. Pregnancy loss rates after mid-trimester amniocentesis. Obstet Gynecol. 2006;108:1067-72.
- Kong CW, Leung TN, Leung TY, Chan LW, Sahota DS, Fung TY, et al. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis. Prenat Diagn. 2006;26:925-30. doi: 10.1002/pd.1528.
- Won RH, Currier RJ, Lorey F, Towner DR. The timing of demise in fetuses with trisomy 21 and trisomy 18. Prenat Diagn. 2005; 25: 60811. doi: 10.1002/pd.1243.
- Wah YM, Leung TY, Cheng YKY, Sahota DS. Procedure-related fetal loss following chorionic villus sampling after first-trimester aneuploidy screening. Fetal Diagn Ther. 2017;41:184-90. doi: 10.1159/000447538.
- Canadian agency for drugs and technologies and health. Non-invasive prenatal testing: a review of the cost effectiveness and guidelines. Accessed October 30th at: https://www.ncbi.nlm.nih.gov/books/NBK274056/
- Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol. 2013;42:15-33. doi: 10.1002/uog.12513.
- Jummaat F, Ahmad S, Mohamed Ismail NA. 5-Year review on amniocentesis and its maternal fetal complications. Horm Mol Biol Clin Investig. 2019;40. doi: 10.1515/hmbci-2019-0006.